These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 215005)
1. Selected animal models for systematic antiatherosclerotic drug development. Day CE; Schurr PE; Phillips WA Adv Exp Med Biol; 1978; 109():277-83. PubMed ID: 215005 [TBL] [Abstract][Full Text] [Related]
2. Animal models for an integrated approach to the pharmacologic control of atherosclerosis. Day CE; Phillips WA; Schurr PE Artery; 1979 Feb; 5(2):90-109. PubMed ID: 120168 [TBL] [Abstract][Full Text] [Related]
3. The characterization of serum lipoproteins from portacaval shunted Macaca fasicularis monkeys. Nelson CA; Casali RE; Morris MD Biochem Med; 1979 Aug; 22(1):110-8. PubMed ID: 227371 [No Abstract] [Full Text] [Related]
4. Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness. Rudel LL; Johnson FL; Sawyer JK; Wilson MS; Parks JS Am J Clin Nutr; 1995 Aug; 62(2):463S-470S. PubMed ID: 7625361 [TBL] [Abstract][Full Text] [Related]
5. [Blood lipoproteins in modeling of atherosclerosis and administration of protamine]. Bozhko GKh; Voloshin PV; Boĭko TP; Kostiukovskaia LS Biull Eksp Biol Med; 1991 Jul; 112(7):44-6. PubMed ID: 1793851 [TBL] [Abstract][Full Text] [Related]
6. [Vasoprotective and vasoaggressive characteristics of serum lipoproteins]. Mertz DP MMW Munch Med Wochenschr; 1978 Dec; 120(50):1671-2. PubMed ID: 214704 [No Abstract] [Full Text] [Related]
7. [Current approaches to the diagnosis and correction of atherogenic dyslipoproteinemia]. Oganov RG; Perova NV Kardiologiia; 1989 Oct; 29(10):15-22. PubMed ID: 2615152 [No Abstract] [Full Text] [Related]
8. [Effect of 5alpha-androstan-3beta, 17beta-diol on serum lipids and lipoproteins and the development of experimental atherosclerosis]. Sharkevich IN Probl Endokrinol (Mosk); 1977; 23(4):99-104. PubMed ID: 198769 [TBL] [Abstract][Full Text] [Related]
9. Dietary induction of hypercholesterolemia and atherosclerosis in Japanese quail of strain SEA. Radcliffe JD; Liebsch KS J Nutr; 1985 Sep; 115(9):1154-61. PubMed ID: 4032062 [TBL] [Abstract][Full Text] [Related]
10. [High-density lipoproteins and arteriosclerosis]. Klimow AN Przegl Lek; 1984; 41(6):417-22. PubMed ID: 6505250 [No Abstract] [Full Text] [Related]
12. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents. Davidson MH Am J Cardiol; 2001 Feb; 87(4A):1A-7A. PubMed ID: 11243600 [No Abstract] [Full Text] [Related]
14. Identification of apolipoproteins in lipoprotein density classes of hypercholesterolemia (type IIa). Lee DM FEBS Lett; 1975 Mar; 51(1):116-20. PubMed ID: 164374 [No Abstract] [Full Text] [Related]
15. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans]. Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165 [TBL] [Abstract][Full Text] [Related]
16. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression. Moriel P; Okawabata FS; Abdalla DS IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Goldberg IJ; Le NA; Ginsberg HN; Paterniti JR; Brown WV Am J Physiol; 1983 Feb; 244(2):E196-201. PubMed ID: 6824074 [TBL] [Abstract][Full Text] [Related]
18. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis]. Gasilin VS; Kurdanov KhA Ter Arkh; 1981; 53(8):130-8. PubMed ID: 7027512 [No Abstract] [Full Text] [Related]
19. [Metformin, lipids and atherosclerosis]. Joffroy-Lavieuville M; Triadou N; Noel M Journ Annu Diabetol Hotel Dieu; 1984; ():361-6. PubMed ID: 6399538 [No Abstract] [Full Text] [Related]